UnitedHealth Just Raised Guidance for the Third Time This Year. Where Will the Stock Be in 3 Years?

Key points

• UnitedHealth raised its 2026–2029 earnings trajectory again, with the latest target lifting to at least $20.50 in adjusted EPS for 2026 and guiding continued growth through 2029.
• The company attributes the improvement to operational simplification, leadership strengthening, and a sharper focus on its core U.S. healthcare business, including exiting certain international ventures.
• Optum, the services and technology arm, turned in a dramatic year-over-year improvement in Q3, with Optum Health generating $735 million in operating earnings and a 3.2% operating margin, up from $41 million and 0.2% a year earlier.
• AI investments are central to the growth plan, with nearly $1.5 billion slated for 2026 to enhance productivity and healthcare navigation through AI-enabled solutions.
• Three earnings-growth scenarios are outlined: a base/conservative path around 13%–14.5% annual growth yielding mid-range stock targets; a higher-growth path approaching 16% that could lift the stock toward roughly $672 if an 18–21x multiple is realized; and a robust outcome with about 70% upside if performance exceeds expectations.
• The forward-looking outlook is tempered by ongoing regulatory investigations into Medicare Advantage practices, along with exposure to rising medical costs and potential changes in government reimbursement.
• Fundamental momentum appears to be building, suggesting the next few years could be rewarding if earnings continue to climb and strategic initiatives, particularly in Optum and AI, deliver on their promises.